Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-08 Sale |
2025-04-08 7:40 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
2,708 | $14.82 | $40,133 | 64,732 (Direct) |
View |
| 2025-04-08 Sale |
2025-04-08 7:38 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER |
1,028 | $14.82 | $15,235 | 24,267 (Direct) |
View |
| 2025-03-26 Sale |
2025-03-26 8:10 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER |
1,095 | $17.05 | $18,670 | 56,363 (Direct) |
View |
| 2025-03-26 Sale |
2025-03-26 8:06 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
3,171 | $17.05 | $54,066 | 218,738 (Direct) |
View |
| 2025-03-05 Sale |
2025-03-06 6:30 pm |
ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director |
4,919 | $18.23 | $89,673 | 17,595 (Direct) |
View |
| 2025-02-24 Sale |
2025-02-25 6:48 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER |
475 | $19.96 | $9,481 | 20,228 (Direct) |
View |
| 2025-02-24 Sale |
2025-02-25 6:46 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
773 | $19.96 | $15,429 | 53,882 (Direct) |
View |
| 2024-11-19 Sale |
2024-11-19 8:43 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL |
10,329 | $16.81 | $173,630 | 81,931 (Direct) |
View |
| 2024-11-19 Sale |
2024-11-19 8:41 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER |
4,073 | $16.81 | $68,467 | 27,795 (Direct) |
View |
| 2024-11-19 Sale |
2024-11-19 8:40 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
10,259 | $16.81 | $172,454 | 73,128 (Direct) |
View |
| 2024-08-19 Sale |
2024-08-20 6:46 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
9,733 | $15.28 | $148,720 | 43,735 (Direct) |
View |
| 2024-08-19 Sale |
2024-08-20 6:43 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL |
9,534 | $15.28 | $145,680 | 52,177 (Direct) |
View |
| 2024-08-19 Sale |
2024-08-20 6:40 pm |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
31,747 | $15.28 | $485,094 | 186,555 (Direct) |
View |
| 2024-06-10 Sale |
2024-06-11 6:00 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
975 | $14.79 | $14,420 | 34,564 (Direct) |
View |
| 2024-05-02 Sale |
2024-05-03 6:00 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
3,503 | $16.94 | $59,341 | 52,498 (Direct) |
View |
| 2024-05-02 Sale |
2024-05-03 6:00 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL |
3,477 | $16.94 | $58,900 | 62,578 (Direct) |
View |
| 2024-05-02 Sale |
2024-05-03 6:00 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER |
1,326 | $16.94 | $22,462 | 22,158 (Direct) |
View |
| 2024-05-02 Sale |
2024-05-03 6:00 pm |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
11,427 | $16.94 | $193,573 | 222,404 (Direct) |
View |
| 2024-04-08 Sale |
2024-04-09 6:00 pm |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
26,574 | $17.87 | $474,877 | 317,600 (Direct) |
View |
| 2024-04-08 Sale |
2024-04-09 6:00 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL |
2,568 | $17.87 | $45,890 | 48,844 (Direct) |
View |
| 2024-04-08 Sale |
2024-04-09 6:00 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER |
1,790 | $17.87 | $31,987 | 17,120 (Direct) |
View |
| 2024-04-08 Sale |
2024-04-09 6:00 pm |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
2,716 | $17.87 | $48,535 | 39,293 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-05 Exercise |
2025-04-08 7:40 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
5,275 | $0 | 64,732 (Direct) |
View |
| 2025-04-05 Exercise |
2025-04-08 7:38 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER |
2,010 | $0 | 24,267 (Direct) |
View |
| 2025-03-24 Option Award |
2025-03-26 8:10 pm |
N/A 2035-03-23 |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER |
28,662 | $0 | 56,363 (Direct) |
View |
| 2025-03-25 Exercise |
2025-03-26 8:10 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER |
2,142 | $0 | 56,363 (Direct) |
View |
| 2025-03-24 Option Award |
2025-03-26 8:06 pm |
N/A 2035-03-23 |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
143,313 | $0 | 218,738 (Direct) |
View |
| 2025-03-25 Exercise |
2025-03-26 8:06 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
6,178 | $0 | 218,738 (Direct) |
View |
| 2025-03-24 Option Award |
2025-03-26 8:03 pm |
N/A 2035-03-23 |
ACADIA PHARMACEUTICALS INC | ACAD | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC |
132,351 | $0 | 133,371 (Direct) |
View |
| 2025-03-24 Option Award |
2025-03-26 7:52 pm |
N/A 2035-03-23 |
ACADIA PHARMACEUTICALS INC | ACAD | Thompson Elizabeth H.Z. EVP, Head of Research & Dev |
118,256 | $0 | 118,256 (Direct) |
View |
| 2025-03-24 Option Award |
2025-03-26 7:49 pm |
N/A 2035-03-23 |
ACADIA PHARMACEUTICALS INC | ACAD | Owen Adams Catherine Chief Executive Officer |
414,015 | $0 | 414,015 (Direct) |
View |
| 2025-02-23 Exercise |
2025-02-25 6:48 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER |
840 | $0 | 20,228 (Direct) |
View |
| 2025-02-23 Exercise |
2025-02-25 6:46 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
1,353 | $0 | 53,882 (Direct) |
View |
| 2024-12-09 Option Award |
2024-12-10 6:33 pm |
N/A 2034-12-08 |
ACADIA PHARMACEUTICALS INC | ACAD | Garner Thomas EVP, Chief Commercial Officer |
281,221 | $0 | 281,221 (Direct) |
View |
| 2024-11-17 Exercise |
2024-11-19 8:43 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL |
19,826 | $0 | 81,931 (Direct) |
View |
| 2024-11-17 Exercise |
2024-11-19 8:41 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER |
7,930 | $0 | 27,795 (Direct) |
View |
| 2024-11-17 Exercise |
2024-11-19 8:40 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
19,826 | $0 | 73,128 (Direct) |
View |
| 2024-10-12 Exercise |
2024-10-15 6:05 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Ndu Adora Director |
4,381 | $0 | 15,414 (Direct) |
View |
| 2024-09-23 Option Award |
2024-09-25 6:53 pm |
N/A 2034-09-22 |
ACADIA PHARMACEUTICALS INC | ACAD | Adams Catherine Owen Chief Executive Officer |
353,261 | $0 | 353,261 (Direct) |
View |
| 2024-08-16 Option Award |
2024-08-20 6:46 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
18,904 | $0 | 43,735 (Direct) |
View |
| 2024-08-16 Option Award |
2024-08-20 6:43 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL |
18,653 | $0 | 52,177 (Direct) |
View |
| 2024-08-16 Option Award |
2024-08-20 6:40 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
62,115 | $0 | 186,555 (Direct) |
View |
| 2024-08-12 Option Award |
2024-08-13 6:05 pm |
N/A 2034-08-11 |
ACADIA PHARMACEUTICALS INC | ACAD | Thompson Elizabeth H.Z. EVP, Head of Research & Dev |
389,126 | $0 | 389,126 (Direct) |
View |
| 2024-06-08 Exercise |
2024-06-11 6:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
1,893 | $0 | 34,564 (Direct) |
View |
| 2024-05-29 Option Award |
2024-05-31 6:00 pm |
N/A 2034-05-28 |
ACADIA PHARMACEUTICALS INC | ACAD | Ndu Adora Director |
25,346 | $0 | 36,379 (Direct) |
View |
| 2024-05-29 Exercise |
2024-05-31 6:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Ndu Adora Director |
6,652 | $0 | 36,379 (Direct) |
View |
| 2024-05-29 Option Award |
2024-05-31 6:00 pm |
N/A 2034-05-28 |
ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director |
25,346 | $0 | 47,860 (Direct) |
View |
| 2024-05-29 Exercise |
2024-05-31 6:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director |
6,652 | $0 | 47,860 (Direct) |
View |
| 2024-05-29 Option Award |
2024-05-31 6:00 pm |
N/A 2034-05-28 |
ACADIA PHARMACEUTICALS INC | ACAD | Daly James M Director |
25,346 | $0 | 50,000 (Direct) |
View |
| 2024-05-29 Exercise |
2024-05-31 6:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Daly James M Director |
6,652 | $0 | 50,000 (Direct) |
View |
| 2024-05-29 Option Award |
2024-05-31 6:00 pm |
N/A 2034-05-28 |
ACADIA PHARMACEUTICALS INC | ACAD | HARRIGAN EDMUND Director |
25,346 | $0 | 51,000 (Direct) |
View |
| 2024-05-29 Exercise |
2024-05-31 6:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | HARRIGAN EDMUND Director |
6,652 | $0 | 51,000 (Direct) |
View |
| 2024-05-29 Option Award |
2024-05-31 6:00 pm |
N/A 2034-05-28 |
ACADIA PHARMACEUTICALS INC | ACAD | SOLAND DANIEL B Director |
25,346 | $0 | 60,000 (Direct) |
View |
| 2024-05-29 Exercise |
2024-05-31 6:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | SOLAND DANIEL B Director |
6,652 | $0 | 60,000 (Direct) |
View |
| 2024-05-29 Option Award |
2024-05-31 6:00 pm |
N/A 2034-05-28 |
ACADIA PHARMACEUTICALS INC | ACAD | Brege Laura Director |
25,346 | $0 | 45,500 (Direct) |
View |
| 2024-05-29 Exercise |
2024-05-31 6:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Brege Laura Director |
6,652 | $0 | 45,500 (Direct) |
View |
| 2024-05-29 Option Award |
2024-05-31 4:10 pm |
N/A 2034-05-28 |
ACADIA PHARMACEUTICALS INC | ACAD | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner |
82,610 | $0 | 39,619,339 (Indirect) |
View |
| 2024-05-01 Exercise |
2024-05-03 6:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
6,814 | $0 | 52,498 (Direct) |
View |
| 2024-05-01 Exercise |
2024-05-03 6:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL |
6,814 | $0 | 62,578 (Direct) |
View |
| 2024-05-01 Exercise |
2024-05-03 6:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER |
2,596 | $0 | 22,158 (Direct) |
View |
| 2024-05-01 Exercise |
2024-05-03 6:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
22,391 | $0 | 222,404 (Direct) |
View |
| 2024-04-05 Exercise |
2024-04-09 6:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | DAVIS STEPHEN CEO |
51,999 | $0 | 317,600 (Direct) |
View |
| 2024-04-05 Exercise |
2024-04-09 6:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL |
5,024 | $0 | 48,844 (Direct) |
View |
| 2024-04-05 Exercise |
2024-04-09 6:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER |
3,499 | $0 | 17,120 (Direct) |
View |
| 2024-04-05 Exercise |
2024-04-09 6:00 pm |
N/A N/A |
ACADIA PHARMACEUTICALS INC | ACAD | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER |
5,275 | $0 | 39,293 (Direct) |
View |
| 2024-03-25 Option Award |
2024-03-27 8:02 pm |
N/A 2034-03-24 |
ACADIA PHARMACEUTICALS INC | ACAD | Kihara James PRINCIPAL ACCOUNTING OFFICER |
22,532 | $0 | 22,532 (Direct) |
View |